BioCardia, Inc. Basic Shares Outstanding (Weighted Average)
BioCardia, Inc. (BCDA) reported Basic Shares Outstanding (Weighted Average) of 12.09 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- BioCardia, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 12.09M shares, a 139.01% increase year-over-year.
- BioCardia, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 10.81M shares, a 133.24% increase year-over-year.
- BioCardia, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 10.68M shares, a 132.73% increase year-over-year.
- BioCardia, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 6.28M shares, a 122.03% increase year-over-year.
- BioCardia, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 6.67M shares, a 142.98% increase from fiscal 2024.
- BioCardia, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 2.74M shares, a 94.32% increase from fiscal 2023.
- BioCardia, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 1.41M shares, a 92.03% decline from fiscal 2022.
- BioCardia, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 17.72M shares, a 4.75% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 12.09M shares 10-Q · filed 2026-08-12 | 11.46M shares 10-Q · filed 2026-08-12 | 11.19M shares derived: average of 3 quarters · filed 2026-08-12 | 9.96M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | 10.81M shares 10-Q · filed 2026-05-15 | 10.74M shares derived: average of 2 quarters · filed 2026-05-15 | 9.26M shares derived: average of 3 quarters · filed 2026-05-15 | 8.21M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2025-12-31 | 10.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 8.48M shares derived: average of 2 quarters · filed 2026-03-24 | 7.34M shares derived: average of 3 quarters · filed 2026-03-24 | 6.67M shares 10-K · filed 2026-03-24 | ||||
| 2025-09-30 | 6.28M shares 10-Q · filed 2025-11-12 | 5.67M shares derived: average of 2 quarters · filed 2025-11-12 | 5.33M shares 10-Q · filed 2025-11-12 | 5.14M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2025-06-30 | 5.06M shares 10-Q/A · filed 2025-10-29 | 4.85M shares 10-Q/A · filed 2025-10-29 | 4.76M shares derived: average of 3 quarters · filed 2026-05-15 | 4.28M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2025-03-31 | 4.64M shares 10-Q · filed 2026-05-15 | 4.61M shares derived: average of 2 quarters · filed 2026-05-15 | 4.02M shares derived: average of 3 quarters · filed 2026-05-15 | 3.48M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | 4.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 3.71M shares derived: average of 2 quarters · filed 2026-03-24 | 3.10M shares derived: average of 3 quarters · filed 2026-03-24 | 2.74M shares 10-K · filed 2026-03-24 | ||||
| 2024-09-30 | 2.83M shares 10-Q · filed 2025-11-12 | 2.35M shares derived: average of 2 quarters · filed 2025-11-12 | 2.13M shares 10-Q · filed 2025-11-12 | 1.97M shares derived: average of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | 1.88M shares 10-Q/A · filed 2025-10-29 | 1.78M shares 10-Q/A · filed 2025-10-29 | 1.68M shares derived: average of 3 quarters · filed 2025-10-29 | 1.62M shares derived: average of 4 quarters · filed 2025-10-29 | ||||
| 2024-03-31 | 1.68M shares 10-Q · filed 2025-05-14 | 25.13M shares 10-Q · filed 2024-05-14 | 1.59M shares derived: average of 2 quarters · filed 2025-05-14 | 1.54M shares derived: average of 3 quarters · filed 2025-05-14 | 1.49M shares derived: average of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | 1.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | 1.47M shares derived: average of 2 quarters · filed 2025-03-26 | 1.43M shares derived: average of 3 quarters · filed 2025-03-26 | 1.41M shares 10-K · filed 2025-03-26 | 21.18M shares 10-K · filed 2024-03-27 | |||
| 2023-09-30 | 1.44M shares 10-Q · filed 2024-11-13 | 21.62M shares 10-Q · filed 2023-11-08 | 1.40M shares derived: average of 2 quarters · filed 2024-11-13 | 1.38M shares 10-Q · filed 2024-11-13 | 20.73M shares 10-Q · filed 2023-11-08 | 10.32M shares derived: average of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | 1.36M shares 10-Q · filed 2024-08-13 | 20.38M shares 10-Q · filed 2023-08-09 | 1.35M shares 10-Q · filed 2024-08-13 | 20.28M shares 10-Q · filed 2023-08-09 | 13.28M shares derived: average of 3 quarters · filed 2024-08-13 | 14.42M shares derived: average of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | 20.18M shares 10-Q · filed 2024-05-14 | 19.24M shares derived: average of 2 quarters · filed 2024-05-14 | 18.78M shares derived: average of 3 quarters · filed 2024-05-14 | 18.50M shares derived: average of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | 18.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | 18.08M shares derived: average of 2 quarters · filed 2024-03-27 | 17.94M shares derived: average of 3 quarters · filed 2024-03-27 | 17.72M shares 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | 17.84M shares 10-Q · filed 2023-11-08 | 17.75M shares derived: average of 2 quarters · filed 2023-11-08 | 17.52M shares 10-Q · filed 2023-11-08 | 17.41M shares derived: average of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | 17.65M shares 10-Q · filed 2023-08-09 | 17.36M shares 10-Q · filed 2023-08-09 | 17.26M shares derived: average of 3 quarters · filed 2023-08-09 | 17.21M shares derived: average of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | 17.07M shares 10-Q · filed 2023-05-10 | 17.07M shares derived: average of 2 quarters · filed 2023-05-10 | 17.07M shares derived: average of 3 quarters · filed 2023-05-10 | 17.06M shares derived: average of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | 17.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | 17.07M shares derived: average of 2 quarters · filed 2023-03-29 | 17.06M shares derived: average of 3 quarters · filed 2023-03-29 | 16.92M shares 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | 17.07M shares 10-Q · filed 2022-11-09 | 17.06M shares derived: average of 2 quarters · filed 2022-11-09 | 16.87M shares 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | 17.05M shares 10-Q · filed 2022-08-10 | 16.81M shares 10-Q · filed 2022-08-10 | ||||||
| 2021-03-31 | 16.57M shares 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |